Bausch Health Companies Inc BHC
$6.51
+2.68%
at last close
Market Cap$2.32 billion
P/E Ratio—
Div Yield—
Volume2.56M
52-Week Range
$4.33$8.69
Analyst Ratings
- Consensus
- Hold — 0 Buy · 3 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $8.00 (+22.9% upside)
Key Stats
- Today's Range
- $6.18 – $6.53
- 50-Day Range
- $4.33 – $7.30
- 52-Week Range
- $4.33 – $8.69
- Volume
- 2.56 million shs
- Average Volume
- 4.15 million shs
- Market Cap
- $2.32 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 3.80%
- Days to Cover
- 4.27
About Bausch Health Companies Inc
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Related Stocks
Compare head-to-head: BHC vs LLY·BHC vs JNJ·BHC vs ABBV·BHC vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.